MJH Life Sciences Prices $430 Million Loan at a Steep Discount

A $430 million leveraged loan to help fund an acquisition by MJH Life Sciences was priced at one of the steepest discounts of 2025 amid investor wariness about some risky debt deals.

The loan was issuedBloomberg Terminal at a discounted price of 96.5 cents on the dollar, the largest in two monthsBloomberg Terminal, according to data compiled by Bloomberg. Just eight deals this year have been completed at a lower level. The Bank of America Corp-led loan as a margin 3.75 percentage points over benchmark.